| NDC Code | 71336-1001-1 |
|---|
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (71336-1001-1) / 1 mL in 1 VIAL, SINGLE-USE |
|---|
| Product NDC | 71336-1001 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Givlaari |
|---|
| Non-Proprietary Name | Givosiran Sodium |
|---|
| Dosage Form | INJECTION, SOLUTION |
|---|
| Usage | SUBCUTANEOUS |
|---|
| Start Marketing Date | 20191212 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA212194 |
|---|
| Manufacturer | Alnylam Pharmaceuticals, Inc. |
|---|
| Substance Name | GIVOSIRAN SODIUM |
|---|
| Strength | 189 |
|---|
| Strength Unit | mg/mL |
|---|
| Pharmacy Classes | Aminolevulinate Synthase 1-directed RNA Interaction [EPC], Decreased RNA Integrity [PE], RNA, Small Interfering [CS], Small Interfering RNA [EPC] |
|---|